Valuation
- Market cap
- —
- Revenue TTM
- $8,030,000
- Net income TTM
- $-1,200,000
- P/E (trailing)
- —
- P/E (forward)
- 0.00
- Profit margin
- -14.94%
- Debt to equity
- —
Trading
- Volume
- —
- Avg volume
- —
- Day's range
- $25.27 – $25.27
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at...
Show more
The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets in component securities that make up the index. The fund is non-diversified.
Latest news
No headlines yet.
